Do you have a new product, new business focus, or a company to showcase?
Increase your exposure with a Business Insight in PharmaTimes Magazine. Our flexible package means you can submit your own copy and photos, or utilise the services of our professional writers and/or photographer to ensure you communicate the best possible message to your audience.
So why not talk to our business development team about Business Insight opportunities with PharmaTimes. After all, a Business Insight in PharmaTimes Magazine offers a unique opportunity to raise your company's profile in the pharmaceutical world.
Why not see what a PharmaTimes Business insight can do for your company?
Contact: anna.yeardley@pharmatimes.com, tel. +44 (0)20 7240 6999.
While there has been tremendous progress in the treatment of rheumatoid arthritis, it remains a debilitating disease that causes a significant socioeconomic impact on societies around the world. As such, researchers are striving to find innovative new treatment options to help more patients reach remission.
AbbVie provided funding and editorial input into this article.
The coronavirus has forced industry to change gear, change how it communicates and, above all, change its perspective. Despite the earth- shattering turbulence of COVID-19, however, Andy Hayley from TBWA\ WorldHealth believes positive lessons and practices will emerge
Cassells has 20 years’ experience in the medical device industry, leading a number of international expansion projects and holding senior management positions in a number of multinational companies including Medtronic, Conor Medsystems, Kinetic Concepts and American Medical Systems. He is now managing director of connected health medtech company Renew Health
Jeremy Thorpe, managing director of Tillotts Pharma UK (Tillotts), tells us how his company has entered the UK and grown from strength to strength over the past six years, overcoming numerous challenges to establish Tillotts’ significant presence in the GI market
Rising expectations from payers and prescribers demand a step change in the way companies engage with them
M&A and diversification have left pharma portfolios with an abundance of underinvested medicines, but they needn’t be ignored
The sequencing of patients’ genes has opened the way for exciting new approaches to therapy. The challenge for the pharmaceutical and life sciences sectors is to adapt R&D, production and sales and marketing to become swift, agile developers of more specialised drugs with smaller target audiences
When it comes to the essential task of coaching customer- facing teams, first-line managers need more than just models, tools and templates; they need the right mind-set too
The often unsung heroes of pharma were celebrated this month as part of the BHBIA's celebration of 10 years of business intelligence excellence
Recruitment agencies provide the unique bridge to bring companies and the right candidates together – something recruitment consultancy Zenopa has been doing for the past 25 years
Does the tendency to use more than one recruitment agency to fill a vacancy add vIalue or is it counterproductive? Recruitment consultancy Zenopa explores the issue
Recruitment in the pharmaceutical industry has become a whole new ball game recently. And the pressure to find the right person for the right job is made more difficult by a lack of candidates with the right experience and skills sets across the board.
As clinical trials have become more and more complex, so has trial monitoring - but a risk-based monitoring approach can make it more efficient
Research has linked improved wellbeing with a wide-range of health benefits, including better cancer outcomes, lower risk of heart disease and stroke, and stronger immune and endocrine systems.
GROWTH FACTOR - Bharat Shah, Director and Co-founder of Sigma, talks about his experience of growing a business with help from Royal Bank of Scotland
Truth & transparency - What pharma needs to keep in mind in the wake of investigations into payments to doctors
How to... make the most of your banking relationship - In a highly competitive and fast-moving sector, it’s no surprise that pharmaceutical companies need access to finance to stand out from the crowd
Changes to the 2015 Code - The new provisions of the 2015 ABPI Code of Practice will become fully effective from 1 May 2015...
Royal Bank of Scotland: "no two businesses are the same"
RBS' pharma team talks to us about how they are continuing to support the industry – with specialist insight
Ashfield Healthcare offers a wide range of tailored solutions through its unique multi-channel approach to specialised healthcare services. But what makes these services unique? Helen Miles explains
Market access and a greater focus on specialist medicines are key to Takeda UK’s drive to be best in class for employees and customers
The relentless pressure on the NHS is felt not just in balance sheets but at the frontline of care. By moving chemotherapy out of the hospital, Pierre Fabre can help both patients and the NHS
Healthcare professionals use the internet every day for a variety of professional purposes from keeping up to date with news, accessing their email and engaging in online communities to completing ongoing CPD courses, or viewing vital clinical resources via their NHS intranets
A family-run company overlaid with the corporate culture of a pharmaceutical multinational may sound like a tricky balancing act. But it can offer the best of both worlds
Learning: the new business strategy
. Learning and development should be a journey but it should also be part of the company culture and business strategy, says Gary Killington, director of PI Partnership
How can pharma engage directly with HCPs inside the NHS?
With so many different online resources to choose from, the internet is becoming an increasingly competitive space in which to engage with healthcare professionals
The learning journey doesn't stop with training.
Pharma needs to invest in its people and look at learning and development not just inside the classroom, but holistically, in order to succeed in the relationship game, says Gary Killington, director of PI Partnership
A ground-breaking approach to COPD management – AstraZeneca rolls out their 'intelligent pharmaceuticals' initiative
Moving 'beyond the push' and offering doctors a smorgasbord of information is the big marketing challenge for pharma, says Dr Tim Ringrose, CEO of M3 Europe
Keeping risk in proportion
- Chris Simmons of Covance explains the importance of adopting a risk-based approach to clinical trials
Financing to fit
. RBS supports healthcare companies through their lifecycle, from start-up to maturity
Market research and data analysis are critical if pharma is to see better outcomes, say the winning entries of this year's Best Of Business Intelligence awards
